Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01459861 · ClinicalTrials.gov registry record · NA
Early Ambulation After Adductor Canal Block for Total Knee Arthroplasty
A NA study, sponsored by Trinity Health Of New England.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01459861: Clinical Trial NA study, sponsored by Trinity Health Of New England.
NCT01459861 is a NA study that was terminated before completion, run by Trinity Health Of New England. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01459861, a NA study, was terminated before completion, sponsored by Trinity Health Of New England.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to assess early ambulation following total knee replacement in patients receiving continuous adductor canal block with posterior capsular injection compared to continuous femoral nerve block with tibial nerve block.
Primary Outcome
Ability to ambulate and perform tasks of the rehabilitation program and reach rehabilitation milestones after total knee arthroplasty.
Interventions
- PROCEDURE Canal Block and Capsular Injection
- PROCEDURE Femoral Nerve Block with Tibial Nerve Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-09 |
| Phase | NA |
Why NCT01459861 stopped before completion
NCT01459861 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Canal Block and Capsular Injection is the first listed.
NCT01459861 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01459861 about?
NCT01459861 is a clinical study titled "Early Ambulation After Adductor Canal Block for Total Knee Arthroplasty". The purpose of this study is to assess early ambulation following total knee replacement in patients receiving continuous adductor canal block with posterior capsular injection compared to continuous femoral nerve block with tibial nerve block.
What is the current status of trial NCT01459861?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2011-10. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01459861?
The interventions under investigation include: Canal Block and Capsular Injection (PROCEDURE), Femoral Nerve Block with Tibial Nerve Block (PROCEDURE).
Who is sponsoring clinical trial NCT01459861?
This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01459861's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia